As the Malawi HIV programme raised the CD4 thresholds for ART eligibility from 250 to 350 cells/μL in 2011 to 500 cells/μl in 2014 13 , 18 , 19 , a clear trend in declining annual TB rates among ART patients was observed between 2008 and 2014.
← all excerpts
The shift in tuberculosis timing among people living with HIV in the course of antiretroviral therapy scale-up in Malawi.
1
—
—